Literature DB >> 15380862

The regional cerebral blood flow changes in major depressive disorder with and without psychotic features.

Ali Saffet Gonul1, Mustafa Kula, Arzu Guler Bilgin, Ahmet Tutus, Aslan Oguz.   

Abstract

Depressive patients with psychotic features demonstrate distinct biological abnormalities in the hypothalamic-pituitary-adrenal axis (HPA), dopaminergic activity, electroencephalogram sleep profiles and measures of serotonergic function when compared to nonpsychotic depressive patients. However, very few functional neuroimaging studies were specifically designed for studying the effects of psychotic features on neuroimaging findings in depressed patients. The objective of the present study was to compare brain Single Photon Emission Tomography (SPECT) images in a group of unmedicated depressive patients with and without psychotic features. Twenty-eight patients who fully met DSM-IV criteria for major depressive disorder (MDD, 12 had psychotic features) were included in the study. They were compared with 16 control subjects matched for age, gender and education. Both psychotic and nonpsychotic depressed patients showed significantly lower regional cerebral blood flow (rCBF) values in the left and right superior frontal cortex, and left anterior cingulate cortex compared to those of controls. In comparison with depressive patients without psychotic features (DwoPF), depressive patients with psychotic features (DwPF) showed significantly lower rCBF perfusion ratios in left parietal cortex, left cerebellum but had higher rCBF perfusion ratio in the left inferior frontal cortex and caudate nucleus. The present study showed that DwPF have a different rCBF pattern compared to patients without psychotic features. Abnormalities involving inferior frontal cortex, striatum and cerebellum may play an important role in the generation of psychotic symptoms in depression.

Entities:  

Mesh:

Year:  2004        PMID: 15380862     DOI: 10.1016/j.pnpbp.2004.05.036

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

1.  Mice lacking urea transporter UT-B display depression-like behavior.

Authors:  Xin Li; Jianhua Ran; Hong Zhou; Tianluo Lei; Li Zhou; Jingyan Han; Baoxue Yang
Journal:  J Mol Neurosci       Date:  2011-07-13       Impact factor: 3.444

2.  Efficacy and brain mechanism of transcutaneous auricular vagus nerve stimulation for adolescents with mild to moderate depression: Study protocol for a randomized controlled trial.

Authors:  Xue Xiao; Xiaobing Hou; Zhangjing Zhang; Ying Li; Xue Yu; Yanhui Wang; Jing Tian; Ke Xu
Journal:  Pediatr Investig       Date:  2020-06-24

3.  Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression.

Authors:  Margret S H Harris; James L Reilly; Michael E Thase; Matcheri S Keshavan; John A Sweeney
Journal:  Psychiatry Res       Date:  2009-11-10       Impact factor: 3.222

4.  Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data.

Authors:  J P Hamilton; G Chen; M E Thomason; M E Schwartz; I H Gotlib
Journal:  Mol Psychiatry       Date:  2010-05-18       Impact factor: 15.992

Review 5.  A neurocognitive model for understanding treatment action in depression.

Authors:  Matthew B Warren; Abbie Pringle; Catherine J Harmer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

6.  Functional anatomy of autobiographical memory recall deficits in depression.

Authors:  K D Young; K Erickson; A C Nugent; S J Fromm; A G Mallinger; M L Furey; W C Drevets
Journal:  Psychol Med       Date:  2011-07-29       Impact factor: 7.723

7.  Seeking a unified framework for cerebellar function and dysfunction: from circuit operations to cognition.

Authors:  Egidio D'Angelo; Stefano Casali
Journal:  Front Neural Circuits       Date:  2013-01-10       Impact factor: 3.492

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.